Search For "central drugs standard"
Govt expert panel recommends JV firm's vaccine for pneumococcal infections
Updated : 3 years, 7 months ago IST
PCV15 vaccine was developed by Tergene Biotech and manufactured at Auro Vaccines, which is a wholly-owned subsidiary of Aurobindo Pharma with capabilities in vaccines development and manufacturing. Aurobindo Pharma holds 80 per cent stake in the joint venture company, Tergene Biotech.
Read More
World's first intra-nasal vaccine for COVID gets CDSCO nod for restricted
Updated : 3 years, 8 months ago IST
The Central Drugs Standard Control Organization (CDSCO) has approved India's first intra-nasal vaccine for COVID for restricted use in emergency situations in people aged 18 and up.
Read More
CDSCO requests WHO for report that establishes link of medical products by
Updated : 3 years, 9 months ago IST
New Delhi [India], October 6 (ANI): National Regulatory Authority, CDSCO has requested the World Health Organization (WHO) to share the report on the establishment of "causal relation to death" with the medical products manufactured by a Haryana-based company, Maiden Pharmaceutical Limite
Read More
CDSCO takes up urgent investigation on WHO's complaint for India-made coug
Updated : 3 years, 9 months ago IST
New Delhi [India], October 6 (ANI): After the World Health Organization (WHO) issued an alert on four India-made cough and cold syrups used for paediatric groups, the Central Drugs Standard Control Organisation (CDSCO) has taken up an urgent investigation in this regard.
Read More
Delhi HC grants bail to joint drug controller of CDSCO
Updated : 3 years, 10 months ago IST
Delhi [India], September 6 (ANI): The Delhi High Court on Tuesday granted bail to the Joint Drug Controller of the Central Drugs Standard Control Organisation (CDSCO) and a Biocon Biologics executive in a Rs 9 lakh bribery case.
Read More
Biological E announces CDSCO's recommendation of its 14-Valent Pneumococca
Updated : 3 years, 11 months ago IST
Hyderabad (Telangana) [India] September 1 (ANI): Hyderabad-based vaccines manufacturer Biological E Limited announced on Thursday that the Subject Expert Committee (SEC) of the Central Drugs Standard Control Organization (CDSCO) reviewed and approved the Phase III infants clinical trial data
Read More
DCGI chief Venugopal Somani's tenure extended by 3 months
Updated : 3 years, 11 months ago IST
New Delhi [India], August 17 (ANI): The tenure of Dr V G Somani as the Drugs Controller General of India (DCGI) has been extended by three months, according to an order issued by the Union Health Ministry.
Read More
Amrita Vishwa Vidyapeetham develops world's first synthetic jaw-bone graft
Updated : 4 years, 2 months ago IST
New Delhi [India], May 26 (ANI): Amrita Vishwa Vidyapeetham, ranked the fifth-best overall university in India in the 2020 National Institution Ranking Framework (NIRF), has got a landmark approval from the Central Drugs Standard Control Organization (CDSCO) for conducting a pilot clinical t
Read More
Covaxin, Covishield given normal new drug permission in adult population w
Updated : 4 years, 6 months ago IST
New Delhi [India], January 27 (ANI): Union Health Minister Dr Mansukh Mandaviya on Thursday said that the Central Drugs Standard Control Organisation (CDSCO) has now upgraded the permission for Covaxin and Covishield from restricted use in emergency situations to normal new drug permissio
Read More
No recommendations for COVID-19 booster dose by SEC: Sources
Updated : 4 years, 7 months ago IST
New Delhi [India], December 11 (ANI): The Subject Expert Committee (SEC) under Central Drugs Standard Control Organization (CDSCO) has said COVID-19 that booster doses cannot be recommended without clinical trials.
Read More
Subject Expert Committee to meet tomorrow to discuss approval for Covishie
Updated : 4 years, 7 months ago IST
New Delhi [India], December 9 (ANI): The Subject Expert Committee (SEC) under the Central Drugs Standard Control Organization (CDSCO) will hold the first meeting on Friday regarding the COVID-19 booster dose, said sources on Thursday.
Read More
Covaxin for 2-18 yrs: Centre examining Expert Committee recommendations, i
Updated : 4 years, 8 months ago IST
New Delhi [India], November 30 (ANI): The Central government is examining the recommendation of the Subject Expert Committee (SEC) regarding the grant of market authorization of Covaxin for the age group of 2 to 18 years for restricted use in an emergency situation subject to various cond
Read More